TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 277 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $162,064 | -5.9% | 10,476 | -4.4% | 0.00% | 0.0% |
Q2 2023 | $172,197 | -5.3% | 10,961 | -0.6% | 0.00% | 0.0% |
Q1 2023 | $181,741 | +3.3% | 11,028 | -2.2% | 0.00% | 0.0% |
Q4 2022 | $175,952 | +18.9% | 11,279 | -0.9% | 0.00% | 0.0% |
Q3 2022 | $148,000 | -6.3% | 11,380 | +0.9% | 0.00% | 0.0% |
Q2 2022 | $158,000 | +7.5% | 11,279 | +9.8% | 0.00% | 0.0% |
Q1 2022 | $147,000 | +1.4% | 10,273 | -3.7% | 0.00% | 0.0% |
Q4 2021 | $145,000 | -39.3% | 10,673 | -26.9% | 0.00% | -33.3% |
Q3 2021 | $239,000 | -10.2% | 14,600 | -5.3% | 0.00% | -25.0% |
Q2 2021 | $266,000 | -7.6% | 15,419 | -2.4% | 0.00% | 0.0% |
Q1 2021 | $288,000 | -3.0% | 15,797 | -3.2% | 0.00% | -20.0% |
Q4 2020 | $297,000 | +1.7% | 16,314 | -0.5% | 0.01% | 0.0% |
Q3 2020 | $292,000 | -3.9% | 16,389 | -1.2% | 0.01% | -16.7% |
Q2 2020 | $304,000 | +21.1% | 16,585 | +0.5% | 0.01% | 0.0% |
Q1 2020 | $251,000 | -23.0% | 16,505 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $326,000 | +16.4% | 16,505 | +1.2% | 0.01% | 0.0% |
Q3 2019 | $280,000 | – | 16,305 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |